MSI Surgical Solutions adds three new autoclaves to expand ETO sterilization capabilities

MSI Surgical Solutions ("MSI"), an Empire Investment Holdings ("Empire") company, announced today that it has expanded its ETO (Ethylene Oxide) sterilization capabilities through the addition of three new autoclaves. ETO machines are critical in the sterilization of both disposable and reusable items made of rubber or paper products, items that are sensitive to heat or moisture and medical device components including probes, scopes, tubes, cords, wires and leads.

“It was necessary to invest in new equipment to create additional capacity to meet the needs of our customers. In fact, MSI continues to bring in new business as healthcare companies continue to move away from maintaining this capability in-house.”

MSI partners with hospitals and ambulatory centers throughout the Tri-State area, providing FDA regulated contract sterilization solutions, which delivers quality, safety, efficiency and cost-effectiveness. Additionally, MSI provides contract sterilization services to OEMs and distributors of medical devices, supplies and components.

"This expansion is a part of MSI's growth initiative," said David F. Alfonso, chairman and chief executive officer of Empire. "It was necessary to invest in new equipment to create additional capacity to meet the needs of our customers. In fact, MSI continues to bring in new business as healthcare companies continue to move away from maintaining this capability in-house."

The investment is an example of the commitment by Empire to support the growth of its portfolio companies. Empire invests in its companies in all facets including through improvements in infrastructure, technology, human capital, research and development and the purchase of capital goods.